Abstract
The PAX6 gene is a transcription factor expressed early in development, predominantly in the eye, brain and gut. It is well known that mutations in PAX6 may result in aniridia, Peter's anomaly and kertatisis. Here, we present mutation analysis of a patient with aniridia, autism and mental retardation. We identified and characterized a 1.3 Mb deletion that disrupts PAX6 transcriptional activity and deletes additional genes expressed in the brain. Our findings provide continued evidence for the role of PAX6 in neural phenotypes associated with aniridia.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
-
Review
MeSH terms
-
Adolescent
-
Adult
-
Aniridia / complications
-
Aniridia / genetics*
-
Autistic Disorder / complications
-
Autistic Disorder / genetics*
-
Chromosomes, Human, Pair 11 / genetics
-
Eye Proteins / chemistry
-
Eye Proteins / genetics*
-
Female
-
Gene Dosage
-
Homeodomain Proteins / chemistry
-
Homeodomain Proteins / genetics*
-
Humans
-
In Situ Hybridization, Fluorescence
-
Intellectual Disability / complications
-
Intellectual Disability / genetics*
-
Male
-
Oligonucleotide Array Sequence Analysis
-
PAX6 Transcription Factor
-
Paired Box Transcription Factors / chemistry
-
Paired Box Transcription Factors / genetics*
-
Pedigree
-
Phenotype
-
Repressor Proteins / chemistry
-
Repressor Proteins / genetics*
-
Sequence Deletion*
Substances
-
Eye Proteins
-
Homeodomain Proteins
-
PAX6 Transcription Factor
-
PAX6 protein, human
-
Paired Box Transcription Factors
-
Repressor Proteins